Future Resourcing of Clinical Research

 
 

It is widely accepted that a well-resourced and functioning clinical research capability is an essential part of any national infrastructure as it benefits patients, the healthcare delivery system and academia and is a unique selling point for the very large life-sciences industry operating in Ireland.

Clinical Research Development Ireland is co-ordinating an exciting new initiative known as the Future Resourcing of Clinical Research (FRCR) which aims to enhance the level of clinical research in Ireland.

Collaborators in this initiative include key stakeholders such as the CRDI partner institutions and their associated Clinical Research Facilities/Centres, the Health Service Executive, Cancer Trials Ireland, the state funding and enterprise agencies, namely, the Health Research Board, Enterprise Ireland, Science Foundation Ireland and the IDA Ireland, industry representative bodies including the Irish Pharmaceutical Healthcare Association, Irish Medical and Surgical Trade Association, BioPharmaChem Ireland and the Irish MedTech Association.

A Steering Committee for the Future Resourcing of Clinical Research initiative has been convened, comprising senior professionals from all the stakeholder organisations with a mandate to strategically examine and define the optimal future clinical research infrastructure, support, capacity and capability. 

The FRCR Steering Committee is conducting a consultation process and is seeking submissions from all those with an interest in clinical research in Ireland. These submissions will inform a plan that outlines the evidence to support the needs identified and will provide a draft high-level coordination road-map on how best to achieve the desired outcome. The mandate and terms of reference of the Steering Committee can be viewed here and include details of membership, working methods and timelines.

For more information on this initiative, please view video above featuring the FRCR Steering Committee Chair and CRDI Chief Executive, Professor Pat O’Mahony.